Compare ALNT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNT | ABCL |
|---|---|---|
| Founded | 1962 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | ALNT | ABCL |
|---|---|---|
| Price | $65.47 | $2.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $50.33 | $7.75 |
| AVG Volume (30 Days) | 162.5K | ★ 4.8M |
| Earning Date | 03-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ 28.52 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $533,134,000.00 | $35,325,000.00 |
| Revenue This Year | $4.80 | $25.45 |
| Revenue Next Year | $5.42 | $10.07 |
| P/E Ratio | $58.58 | ★ N/A |
| Revenue Growth | N/A | ★ 7.17 |
| 52 Week Low | $19.25 | $1.89 |
| 52 Week High | $70.00 | $6.52 |
| Indicator | ALNT | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 60.07 | 34.92 |
| Support Level | $59.65 | $2.75 |
| Resistance Level | $69.94 | $3.28 |
| Average True Range (ATR) | 3.46 | 0.24 |
| MACD | 0.16 | -0.09 |
| Stochastic Oscillator | 58.67 | 15.95 |
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.